ReviewEvidence-based complementary and alternative medicine : eCAM2022
Review in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 23 citations in OpenAlex.
- Anticancer Activity of Miswak Root Extract in Breast Cancer Cell Line: HRLC-MS/MS Profiling, In Vitro Evaluation, and In Silico Analysis.International journal of molecular sciences · 2026Article
- Impact of Salvadora persica aqueous extract on follicular development in female rats.Biological research · 2026Article
- Antifungal efficacy of Miswak extracts versus sodium hypochlorite against Candida albicans on CAD-CAM denture base: an in-vitro study.BMC complementary medicine and therapies · 2026Article
- Comparison of hyaluronic acid, chlorhexidine and persica during SRP.Bioinformation · 2026Article
- Article
- Exploring antimicrobial properties and oral health benefits of salix subserrata willd: unveiling the potential beyond its use as traditional chewing stick.BMC complementary medicine and therapies · 2025Article
- Review
- Benzyl isothiocyanate exhibits antibacterial and antibiofilm activity againstFrontiers in cellular and infection microbiology · 2025Article
- Improving glass Ionomer performance through plant extracts: a systematic review ofBiomaterial investigations in dentistry · 2025Review
- Plant polyphenols, terpenes, and terpenoids in oral health.Open medicine (Warsaw, Poland) · 2025Review
- Can the Adoption of Salvadora Persica among School-aged Learners Lead to Improved Oral Hygiene Practices?International journal of school health · 2024Article
- Article
- Effect of Salvadora persica on resin-dentin bond stability.BMC oral health · 2024Article
- Kaempferol: A Review of Current Evidence of Its Antiviral Potential.International journal of molecular sciences · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.